ResearcherChanghai HospitalActive in the last 2 years

Zhaoshen Li

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5159593570. Sources: ClinicalTrials.gov.

Their work

Papers: 1
Trials: 1 (principal investigator on 1)
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 trial · 2025: none · 2026: 1 paper

Papers 1

Integrative analysis of lactylation patterns reveals prognostic biomarkers and therapeutic targets in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2026.218536 ↗

Trials 1

Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases Principal investigator NCT06278454 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wenbo Zhu · 1 shared paper, 2026 · strength 0.28
- Paper Integrative analysis of lactylation patterns reveals prognostic biomarkers and therapeutic targets in pancreatic cancer. DOI 10.1016/j.canlet.2026.218536 ↗
Fanyang Kong · 1 shared paper, 2026 · strength 0.28
- Paper Integrative analysis of lactylation patterns reveals prognostic biomarkers and therapeutic targets in pancreatic cancer. DOI 10.1016/j.canlet.2026.218536 ↗
Xiangyu Kong · 1 shared paper, 2026 · strength 0.28
- Paper Integrative analysis of lactylation patterns reveals prognostic biomarkers and therapeutic targets in pancreatic cancer. DOI 10.1016/j.canlet.2026.218536 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.